Back

IGF2 mediates Hippo signaling to control liver size

Zhong, Z.; Jin, R.; Zhong, Y.; Zhang, L.; Chen, D.; Jiao, Z.; Zhou, F.; Zhu, R.; Wu, J.; Dong, R.; Dong, K.; Lan, F.; Wang, Y.; Guan, K.-L.; Yu, F.-X.

2024-10-27 cell biology
10.1101/2024.10.27.620455 bioRxiv
Show abstract

The Hippo pathway is a central mechanism in organ size control, but the mediator for its function remains elusive. Here, we show that the expression of insulin-like growth factor II (IGF2) is directly induced by YAP/TAZ transcription cofactors of the Hippo pathway in a developmental stage- and cell type-specific manner. In mouse livers, Igf2 expression is sustained by YAP/TAZ in hepatoblasts and immature hepatocytes at fetal and neonatal stages, coupling with rapid cell proliferation and liver size expansion, whereas turned off in matured hepatocytes following YAP/TAZ inactivation to prevent liver overgrowth. In contrast, YAP/TAZ fails to regulate Igf2 expression in cholangiocytes and diverse liver mesenchymal cells where epigenetic barriers, including DNA and histone methylation, are implanted near Igf2 promoters. Furthermore, IGF2 activates IGF1R signaling and promotes normal and neoplastic liver growth, while the inactivation of IGF2 or IGF1R effectively blocks YAP/TAZ-induced hepatomegaly and hepatoblastoma. In conclusion, our findings reveal that IGF2 is a bona fide mediator of the Hippo pathway, indicating a fundamental role of the Hippo-IGF2-IGF1R signaling axis in organ size regulation and malignancies.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Nature Communications
○ 5641 papers in training set
Top 10%
18.2%
Similar papers in this journal
2
Gastroenterology
○ 42 papers in training set
Top 0.1%
12.7%
Similar papers in this journal
3
Cell Reports
○ 1498 papers in training set
Top 5%
6.6%
Similar papers in this journal
4
eLife
● 5828 papers in training set
Top 18%
6.6%
Similar papers in this journal
5
iScience
○ 1154 papers in training set
Top 4%
4.3%
Similar papers in this journal
6
Protein & Cell
◐ 25 papers in training set
Top 0.1%
3.4%
50% of probability mass above
7
Science Advances
● 1243 papers in training set
Top 11%
3.2%
8
Cellular and Molecular Gastroenterology and Hepatology
○ 46 papers in training set
Top 0.3%
3.2%
9
Nature Cell Biology
○ 118 papers in training set
Top 1.0%
3.2%
10
Molecular Cell
○ 350 papers in training set
Top 3%
2.4%
11
Developmental Cell
○ 196 papers in training set
Top 2%
2.1%
12
Cell Research
○ 51 papers in training set
Top 0.4%
2.1%
13
Hepatology Communications
○ 22 papers in training set
Top 0.2%
1.9%
14
JHEP Reports
○ 11 papers in training set
Top 0.1%
1.7%
15
Journal of Hepatology
○ 21 papers in training set
Top 0.2%
1.7%
16
Cell
○ 431 papers in training set
Top 7%
1.5%
17
Cell Death & Differentiation
○ 48 papers in training set
Top 0.6%
1.5%
18
Cell Stem Cell
○ 62 papers in training set
Top 1%
1.4%
19
Hepatology
○ 22 papers in training set
Top 0.3%
1.3%
20
Cell Death & Disease
147 papers in training set
Top 2%
1.3%
21
Nature Metabolism
○ 69 papers in training set
Top 2%
1.1%
22
Communications Biology
○ 993 papers in training set
Top 26%
1.0%
23
Advanced Science
○ 286 papers in training set
Top 8%
1.0%
24
Cell Discovery
○ 57 papers in training set
Top 1%
0.8%
25
EMBO Reports
○ 263 papers in training set
Top 7%
0.8%
26
Cell Reports Medicine
○ 153 papers in training set
Top 5%
0.8%
27
Cell Systems
○ 201 papers in training set
Top 6%
0.6%
28
Cell Genomics
○ 172 papers in training set
Top 5%
0.6%
29
Development
● 497 papers in training set
Top 5%
0.6%
30
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 45%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.